Skip to main content
Log in

Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The international normalized ratio (INR) may not be directly applicable to patients with liver disease. We aimed to establish an alternative INR calibration system for patients with liver disease and to evaluate the effect of their use in chronic liver disease patients. Eighty-two patients with liver cirrhosis (LC) were included, and their prothrombin times (PTs) were measured by using 5 commercial thromboplastins. Each of the thromboplastins was also assigned an international sensitivity index (ISIliver) by the plasmas from LC patients. INRvka, INRliver, model for end-stage liver disease (MELD)vka, MELDliver, Child-Pugh (Child)vka, and Childliver scores were calculated. The coefficient of variance of INRvka was significantly larger than that of INRliver (P < 0.01). The mean difference in INRvka between the thromboplastins was also significantly larger than that in INRliver (P < 0.01). The total mean MELDliver score was higher than the total mean MELDvka score. The mean difference between the MELDvka and MELDliver scores (MELD score ≥15) was 3.2 %. We reconfirmed that the use of the alternative calibration system described herein for patients with liver disease may resolve the variability of INR measurement. Our data suggest that we would need to reevaluate the correlation between Child-Pugh class, MELD score, and clinical prognosis by using INRliver for patients with LC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–9.

    Article  CAS  PubMed  Google Scholar 

  2. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–71. doi:10.1053/he.2000.5852.

    Article  CAS  PubMed  Google Scholar 

  3. Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell’Era A, Sei C, Mannucci PM. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology. 2007;46(2):520–7. doi:10.1002/hep.21732.

    Article  PubMed  Google Scholar 

  4. Bellest L, Eschwege V, Poupon R, Chazouilleres O, Robert A. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology. 2007;46(2):528–34. doi:10.1002/hep.21680.

    Article  PubMed  Google Scholar 

  5. Procedures for validation of INR and local calibration of PT/INR systems; approved guideline (Document H54-A). Wayne, Pennsylvania, Clinical and Laboratory Standards Institute; 2005;25(23).

  6. van den Besselaar AM, Barrowcliffe TW, Houbouyan-Reveillard LL, Jespersen J, Johnston M, Poller L. Tripodi. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost. 2004;2(11):1946–53. doi:10.1111/j.1538-7836.2004.00970.x.

    Article  PubMed  Google Scholar 

  7. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline, 5th ed. CLSI Document H21-A5., vol 28. Wayne, Pennsylvania, Clinical and Laboratory Standards Institute; 2008.

  8. World Health Organization Expert Committee on Biological Standardization. Guidelines for thromboplastins and plasma used to control anticoagulant therapy. WHO Tech Rep Ser. 1999;889:64–93.

    Google Scholar 

  9. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45(3):797–805. doi:10.1002/hep.21563.

    Article  PubMed  Google Scholar 

  10. Deitcher SR. Interpretation of the international normalised ratio in patients with liver disease. Lancet. 2002;359(9300):47–8. doi:10.1016/s0140-6736(02)07282-3.

    Article  PubMed  Google Scholar 

  11. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147–56. doi:10.1056/NEJMra1011170.

    Article  CAS  PubMed  Google Scholar 

  12. Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell’Era A, Iannuzzi F, Aghemo A, Mannucci PM. Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology. 2010;52(1):249–55. doi:10.1002/hep.23653.

    Article  CAS  PubMed  Google Scholar 

  13. Poller L, van den Besselaar AM, Jespersen J, Tripodi A, Houghton D. The European Concerted Action on Anticoagulation (ECAA): field studies of coagulometer effects on the ISI of ECAA thromboplastins. Thromb Haemost. 1998;80(4):615–23.

    CAS  PubMed  Google Scholar 

  14. Denson KW, Reed SV, Haddon ME. Validity of the INR system for patients with liver impairment. Thromb Haemost. 1995;73(1):162.

    CAS  PubMed  Google Scholar 

  15. Denson KW, Reed SV, Haddon ME, Woodhams B, Brucato C, Ruiz J. Comparative studies of rabbit and human recombinant tissue factor reagents. Thromb Res. 1999;94(4):255–61.

    Article  CAS  PubMed  Google Scholar 

  16. Coombes JM, Trotter JF. Development of the allocation system for deceased donor liver transplantation. Clin Med Res. 2005;3(2):87–92.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Feyssa E, Ortiz J, Grewal K, Azhar A, Parsikia A, Tufail K, Hashemi N, Brady P, Araya V. MELD score less than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation. Transplantation. 2011;91(7):786–92. doi:10.1097/TP.0b013e31820e014e.

    PubMed  Google Scholar 

  18. Poller L, van den Besselaar AM, Jespersen J, Tripodi A, Houghton D. Correction for lack of coincidence of normal and abnormal calibration slopes in ISI determination. Thromb Haemost. 1999;81(6):935–9.

    CAS  PubMed  Google Scholar 

  19. Tripodi A, Chantarangkul V, Akkawat B, Clerici M, Mannucci PM. A partial factor V deficiency in anticoagulated lyophilized plasmas has been identified as a cause of the international normalized ratio discrepancy in the external quality assessment scheme. Thromb Res. 1995;78(4):283–92.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2010-0024678), supported this work.

Conflict of interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hye Ryoun Kim.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, J.H., Kweon, O.J., Lee, MK. et al. Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease. Int J Hematol 102, 163–169 (2015). https://doi.org/10.1007/s12185-015-1820-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-015-1820-2

Keywords

Navigation